drugset
drugset / Trial / NCT04225052

Clinical Trial to Evaluate the Safety and Pharmacokinetics of YHP1903 in Healthy Volunteers

NCT04225052 ↗

Phase 1 Completed 34 enrolled Yuhan Corporation Chonbuk National University Hospital · collab
RandomizedCrossoverOpen-labelTreatment

Summary

A randomized, open-label, single dose, crossover clinical trial to evaluate the safety and pharmacokinetics of YHP1903 in healthy volunteers

Timeline

Start
2019-12-19
Primary completion
2020-01-08
Completion
2020-01-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Varenicline Small molecule 1 mg —
Subject YHP1903 Unknown 1 mg —

Indications

No indication recorded.